Search
Search Results
##search.searchResults.foundPlural##
-
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1545PDF: 905HTML: 1954Figure: 170Tables: 185ALL revision 1: 190response to reviewer: 180 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2633PDF: 943HTML: 3606 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
842PDF: 487HTML: 1304 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6314PDF: 2112HTML: 14015Untitled: 199figure: 184 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1941PDF: 1166HTML: 266 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1307HTML: 307PDF: 935Suppl. Files: 446 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1364PDF: 529HTML: 198 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2121PDF: 759HTML: 1044Spirometry in SCA patients before transplant: 200Spirometry in SCA patients post transplant: 180 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2129PDF: 1693HTML: 378 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2671PDF: 968HTML: 4703 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4304PDF: 1373HTML: 2039 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3138PDF: 1828HTML: 3583 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
712PDF: 412Suppl. Files: 120HTML: 112 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1298PDF: 1009HTML: 122 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1244PDF: 475HTML: 18573Figure 1: 169Figure 2: 150Figure 3: 168Figure 4: 205Figure 5: 177 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1413PDF: 728HTML: 4550Figure 1: Chest radiograph: 212Figure 2: Flow cytometer analysis of pleural fluid: 183 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2414PDF: 860HTML: 2457 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
724PDF: 466HTML: 6266 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1121PDF: 772HTML: 208 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1258PDF: 528HTML: 23044 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2019PDF: 796HTML: 1036 -
-
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
819PDF: 540HTML: 4019 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4144PDF: 3423HTML: 203 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1391PDF: 680HTML: 1378cover letter: 205 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1278PDF: 607HTML: 3081







